Back to MW MARSHALL WACE, LLP

ANTXANTX
7 quarters

Position history for MWMARSHALL WACE, LLP's holdings in AN2 THERAPEUTICS INC

MARSHALL WACE, LLP previously held 0 shares of ANTX (AN2 THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$11.5M

Total Shares Change

-716,781

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$4.84
0
2026-Q1
New
17,700
-
$60,5340.0%$1.06
29
2024-Q3
Exited
0
-100.0%
$00.0%$1.06
0
2024-Q2
Increased
96,111
+16.5%
$206,6390.0%$2.15
26
2024-Q1
Decreased
82,498
-75.5%
$268,1190.0%$3.25
0
2023-Q4
Decreased
337,321
-52.9%
$6.9M0.0%$20.49
0
2023-Q3
New
716,781
-
$11.5M0.0%$16.08
39

Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used